Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Australia Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20053
20063
20075
20092
20108
20122
20131
20141
20161
20171
20202
20212
20231
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated6
Not yet recruiting2
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
Eli Lilly and Company5
Boehringer Ingelheim3
Novo Nordisk A/S3
Amgen2
AstraZeneca2
Bristol-Myers Squibb2
Zafgen, Inc.2
Bayer1
Calliditas Therapeutics AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 240
Obesity5
Diabetes Mellitus4
Diabetic Nephropathies3
Overweight3
Renal Insufficiency, Chronic3
Albuminuria2
Diabetes Mellitus, Type 12
Glucose Intolerance1
Kidney Failure, Chronic1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.